Global Autologous Cell Therapy Market Analysis 2016-2020 and Forecast 2021-2026
- Report Code : 99S2464155
- Published On: Apr, 2021
- Category : Chemicals & Materials
- Pages : 85
-
The global Autologous Cell Therapy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Autologous Cell Therapy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Bone Marrow
Epidermis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
BioTime, Inc.
BrainStorm Cell Therapeutics
Caladrius Biosciences, Inc.
Fibrocell Science, Inc.
Opexa Therapeutics, Inc.
Pharmicell Co., Inc.
Regeneus Ltd.
TiGenix NV
TxCell SA
U.S. Stem Cell, Inc.
Vericel Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Neurology
Orthopedics
Cancer
Wound Healing
CVD
Autoimmune
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
-
With tables and figures helping analyze worldwide Global Autologous Cell Therapy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview1.1 Autologous Cell Therapy Industry
Figure Autologous Cell Therapy Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Autologous Cell Therapy1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Autologous Cell Therapy
1.2.2 Downstream
Table Application Segment of Autologous Cell Therapy
Table Global Autologous Cell Therapy Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact1.3 Cost Analysis
2 Industry Environment (PEST Analysis)2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Autologous Cell Therapy Market by Type3.1 By Type
3.1.1 Bone Marrow
Table Major Company List of Bone Marrow
3.1.2 Epidermis
Table Major Company List of Epidermis3.2 Market Size
Table Global Autologous Cell Therapy Market 2016-2020, by Type, in USD Million
Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in USD Million
Table Global Autologous Cell Therapy Market 2016-2020, by Type, in Volume
Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in Volume3.3 Market Forecast
Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in USD Million
Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List4.1 BioTime, Inc. (Company Profile, Sales Data etc.)
4.1.1 BioTime, Inc. Profile
Table BioTime, Inc. Overview List
4.1.2 BioTime, Inc. Products & Services
4.1.3 BioTime, Inc. Business Operation Conditions
Table Business Operation of BioTime, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 BrainStorm Cell Therapeutics (Company Profile, Sales Data etc.)
4.2.1 BrainStorm Cell Therapeutics Profile
Table BrainStorm Cell Therapeutics Overview List
4.2.2 BrainStorm Cell Therapeutics Products & Services
4.2.3 BrainStorm Cell Therapeutics Business Operation Conditions
Table Business Operation of BrainStorm Cell Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Caladrius Biosciences, Inc. (Company Profile, Sales Data etc.)
4.3.1 Caladrius Biosciences, Inc. Profile
Table Caladrius Biosciences, Inc. Overview List
4.3.2 Caladrius Biosciences, Inc. Products & Services
4.3.3 Caladrius Biosciences, Inc. Business Operation Conditions
Table Business Operation of Caladrius Biosciences, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 Fibrocell Science, Inc. (Company Profile, Sales Data etc.)
4.4.1 Fibrocell Science, Inc. Profile
Table Fibrocell Science, Inc. Overview List
4.4.2 Fibrocell Science, Inc. Products & Services
4.4.3 Fibrocell Science, Inc. Business Operation Conditions
Table Business Operation of Fibrocell Science, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 Opexa Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.5.1 Opexa Therapeutics, Inc. Profile
Table Opexa Therapeutics, Inc. Overview List
4.5.2 Opexa Therapeutics, Inc. Products & Services
4.5.3 Opexa Therapeutics, Inc. Business Operation Conditions
Table Business Operation of Opexa Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Pharmicell Co., Inc. (Company Profile, Sales Data etc.)
4.6.1 Pharmicell Co., Inc. Profile
Table Pharmicell Co., Inc. Overview List
4.6.2 Pharmicell Co., Inc. Products & Services
4.6.3 Pharmicell Co., Inc. Business Operation Conditions
Table Business Operation of Pharmicell Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Regeneus Ltd. (Company Profile, Sales Data etc.)
4.7.1 Regeneus Ltd. Profile
Table Regeneus Ltd. Overview List
4.7.2 Regeneus Ltd. Products & Services
4.7.3 Regeneus Ltd. Business Operation Conditions
Table Business Operation of Regeneus Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 TiGenix NV (Company Profile, Sales Data etc.)
4.8.1 TiGenix NV Profile
Table TiGenix NV Overview List
4.8.2 TiGenix NV Products & Services
4.8.3 TiGenix NV Business Operation Conditions
Table Business Operation of TiGenix NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 TxCell SA (Company Profile, Sales Data etc.)
4.9.1 TxCell SA Profile
Table TxCell SA Overview List
4.9.2 TxCell SA Products & Services
4.9.3 TxCell SA Business Operation Conditions
Table Business Operation of TxCell SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 U.S. Stem Cell, Inc. (Company Profile, Sales Data etc.)
4.10.1 U.S. Stem Cell, Inc. Profile
Table U.S. Stem Cell, Inc. Overview List
4.10.2 U.S. Stem Cell, Inc. Products & Services
4.10.3 U.S. Stem Cell, Inc. Business Operation Conditions
Table Business Operation of U.S. Stem Cell, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Vericel Corporation (Company Profile, Sales Data etc.)
4.11.1 Vericel Corporation Profile
Table Vericel Corporation Overview List
4.11.2 Vericel Corporation Products & Services
4.11.3 Vericel Corporation Business Operation Conditions
Table Business Operation of Vericel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition5.1 Company Competition
Table Global Autologous Cell Therapy Sales Revenue 2016-2020, by Company, in USD Million
Table Global Autologous Cell Therapy Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Autologous Cell Therapy Sales Revenue Share in 2020, by Company, in USD Million
Table Global Autologous Cell Therapy Sales Volume 2016-2020, by Company, in Volume
Table Global Autologous Cell Therapy Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Autologous Cell Therapy Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by Company
Figure North America Autologous Cell Therapy Market Concentration, in 2020
Figure Europe Autologous Cell Therapy Market Market Concentration, in 2020
Figure Asia-Pacific Autologous Cell Therapy MMarket Concentration, in 2020
Figure South America Autologous Cell Therapy Market Concentration, in 2020
Figure Middle East & Africa Autologous Cell Therapy Market Concentration, in 2020
6 Demand by End Market6.1 Demand Situation
6.1.1 Demand in Neurology
Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in Volume
6.1.2 Demand in Orthopedics
Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in Volume
6.1.3 Demand in Cancer
Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in Volume
6.1.4 Demand in Wound Healing
Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in Volume
6.1.5 Demand in CVD
Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in Volume
6.1.6 Demand in Autoimmune
Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in Volume
6.1.7 Demand in Others
Figure Autologous Cell Therapy Demand in Others, 2016-2020, in USD Million
Figure Autologous Cell Therapy Demand in Others, 2016-2020, in Volume6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions6.3 Demand Forecast
Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in USD Million
Figure Autologous Cell Therapy Market Growth 2021-2026, by Application, in USD Million
Figure Autologous Cell Therapy Market Share in 2026, by Application, in USD Million
Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in Volume
Table Autologous Cell Therapy Market Growth 2021-2026, by Application, in Volume
Table Autologous Cell Therapy Market Share in 2026, by Application, in Volume6.4 Impact of the COVID-19 on the Demand
7 Region Operation7.1 Regional Production
Table Autologous Cell Therapy Production 2016-2020, by Region, in USD Million
Table Autologous Cell Therapy Production 2016-2020, by Region, in Volume7.2 Regional Market
Table Global Autologous Cell Therapy Market 2016-2020, by Region, in USD Million
Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in USD Million
Table Global Autologous Cell Therapy Market 2016-2020, by Region, in Volume
Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in Volume7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million
Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million
Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million
Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million
Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million
Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million
Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export
7.5 Regional Forecast
Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in USD Million
Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
-
The Global Autologous Cell Therapy Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
In recent years, the Global Autologous Cell Therapy Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
According to the Global Autologous Cell Therapy Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
The majority of data for the Global Autologous Cell Therapy Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
